Sawai Group's R&D expenditure FY 2013-2022
In the fiscal year 2022, research and development (R&D) expenses of Sawai Group Holdings Co., Ltd. amounted to around 16 billion Japanese yen. Founded in 1929, Sawai is one of the leading manufacturers of generic pharmaceutical products in Japan.